Long-term mortality assessment of multidrug-resistant tuberculosis patients treated with delamanid

MDR-TB patients treated with 6 months or more of delamanid had significantly lower likelihood of mortality http://ow.ly/HOv1d

Detalles Bibliográficos
Autores principales: Wells, Charles D., Gupta, Rajesh, Hittel, Norbert, Geiter, Lawrence J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2015
Materias:
Agora
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416109/
https://www.ncbi.nlm.nih.gov/pubmed/25700385
http://dx.doi.org/10.1183/09031936.00176314
_version_ 1782369181882122240
author Wells, Charles D.
Gupta, Rajesh
Hittel, Norbert
Geiter, Lawrence J.
author_facet Wells, Charles D.
Gupta, Rajesh
Hittel, Norbert
Geiter, Lawrence J.
author_sort Wells, Charles D.
collection PubMed
description MDR-TB patients treated with 6 months or more of delamanid had significantly lower likelihood of mortality http://ow.ly/HOv1d
format Online
Article
Text
id pubmed-4416109
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-44161092015-05-05 Long-term mortality assessment of multidrug-resistant tuberculosis patients treated with delamanid Wells, Charles D. Gupta, Rajesh Hittel, Norbert Geiter, Lawrence J. Eur Respir J Agora MDR-TB patients treated with 6 months or more of delamanid had significantly lower likelihood of mortality http://ow.ly/HOv1d European Respiratory Society 2015-05 2015-02-19 /pmc/articles/PMC4416109/ /pubmed/25700385 http://dx.doi.org/10.1183/09031936.00176314 Text en Copyright ©ERS 2015 http://creativecommons.org/licenses/by-nc/4.0/ ERJ Open articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0
spellingShingle Agora
Wells, Charles D.
Gupta, Rajesh
Hittel, Norbert
Geiter, Lawrence J.
Long-term mortality assessment of multidrug-resistant tuberculosis patients treated with delamanid
title Long-term mortality assessment of multidrug-resistant tuberculosis patients treated with delamanid
title_full Long-term mortality assessment of multidrug-resistant tuberculosis patients treated with delamanid
title_fullStr Long-term mortality assessment of multidrug-resistant tuberculosis patients treated with delamanid
title_full_unstemmed Long-term mortality assessment of multidrug-resistant tuberculosis patients treated with delamanid
title_short Long-term mortality assessment of multidrug-resistant tuberculosis patients treated with delamanid
title_sort long-term mortality assessment of multidrug-resistant tuberculosis patients treated with delamanid
topic Agora
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416109/
https://www.ncbi.nlm.nih.gov/pubmed/25700385
http://dx.doi.org/10.1183/09031936.00176314
work_keys_str_mv AT wellscharlesd longtermmortalityassessmentofmultidrugresistanttuberculosispatientstreatedwithdelamanid
AT guptarajesh longtermmortalityassessmentofmultidrugresistanttuberculosispatientstreatedwithdelamanid
AT hittelnorbert longtermmortalityassessmentofmultidrugresistanttuberculosispatientstreatedwithdelamanid
AT geiterlawrencej longtermmortalityassessmentofmultidrugresistanttuberculosispatientstreatedwithdelamanid

Ejemplares similares